Comparative Study of the Tomey FT-1000, and Goldmann Applanation Tonometer (GAT)
This study is intended to evaluate the agreement between Intraocular pressure(IOP) measurements obtained with the FT-1000 non-contact tonometer and a GAT to confirm the feasibility of the measurement procedures.
This is a prospective comparative study that will be conducted at one clinical site in the United States. Subjects who sign an informed consent form and fulfill all inclusion and exclusion criteria will undergo FT-1000 measurements followed by Goldmann applanation tonometry during a single study visit.
The primary analysis will be performed using one preselected study eye from each subject. Measurements from the fellow eye, when available, may be summarized as exploratory analyses but will not contribute to the primary effectiveness analysis.
In general, descriptive statistics (n, mean, standard deviation, median, minimum and maximum) will be used to summarize continuous variables. Frequencies and percentages will be used to summarize categorical variables. The number of accepted scans and the total number of scans evaluated will be summarized by scan type, device, and subject population.
Agreement between the FT-1000 and the Goldmann applanation tonometer will be evaluated using the study eye measurements by calculating the mean difference, standard deviation (SD), 95% limits of agreement (LOA), Bland-Altman plots, Deming regression, and Pearson correlation coefficient.
Exploratory analyses may also be performed using fellow-eye measurements.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Male or female subjects 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed.
- Subjects who are able to understand and follow the study procedures and instructions provided by the clinical staff.
- Subjects who voluntarily provide written informed consent.
- Subjects who satisfy all study eligibility requirements and are able to undergo both FT-1000 and Goldmann applanation tonometry measurements during the study visit.
Exclusion Criteria:
- Subjects with only one functional eye.
- Subjects with poor or eccentric fixation in either eye.
- Subjects with a history of corneal surgery, including corneal laser or refractive surgery (e.g., LASIK).
- Subjects with corneal scarring, keratoconus, or any other clinically significant corneal pathology.
- Subjects with an active corneal or conjunctival infection or inflammation in either eye.
- Subjects with microphthalmos or buphthalmos.
- Subjects who are unable or unwilling to remove contact lenses before study measurements.
- Subjects with clinically significant dry eye disease that, in the investigator's opinion, may affect tonometry measurements.
- Subjects with blepharospasm (lid squeezing) or nystagmus that may interfere with accurate measurements.
- Subjects with abnormal central corneal thickness (CCT).
- Subjects with any condition or circumstance that, in the opinion of the investigator, could place the subject at significant risk, interfere with study participation, or confound interpretation of the study results.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Low Intraocular pressure(IOP) Group: 7-16 mmHg
Group with IOP of 7-16 mmHg; 10 subjects.
|
Intraocular pressure measurement by non-contact tonometer and applanation tonometer.
|
|
Middle Intraocular pressure(IOP) Group: >16 to <23 mmHg
Group with IOP of >16 to <23 mmHg; 10 subjects.
|
Intraocular pressure measurement by non-contact tonometer and applanation tonometer.
|
|
High Intraocular pressure(IOP)Group: ≥23 mmHg
Group with IOP of ≥23 mmHg; 10 subjects.
|
Intraocular pressure measurement by non-contact tonometer and applanation tonometer.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Safety of the test devices
Tijdsspanne: Through study completion, approximately 3 days
|
Any adverse events observed or reported during the study visit will be assessed and documented.
|
Through study completion, approximately 3 days
|
|
Agreement of the Intraocular pressure (IOP) mmHg between the test devices and predicate device
Tijdsspanne: Through study completion, approximately 3 days
|
Agreement of the Intraocular pressure (IOP) mmHg between the FT-1000 and the Goldmann Applanation Tonometer(GAT) will be evaluated using the study eye measurements by calculating the mean difference, standard deviation (SD), 95% limits of agreement (LOA), Bland-Altman plots, Deming regression, and Pearson correlation coefficient. Exploratory analyses may also be performed using fellow-eye measurements. |
Through study completion, approximately 3 days
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- TomeyFT-1000-001
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .